The role of s100a12 as a systemic marker of inflammation

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Meijer, B ^a,b   Gearry, R B ^a,b   Day, A S ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; PROTEIN S 100; PROTEIN S 100A12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE OTITIS MEDIA; BEHCET DISEASE; CONFORMATIONAL TRANSITION; CYSTIC FIBROSIS; ENTERITIS; FAMILIAL MEDITERRANEAN FEVER; GLOMERULONEPHRITIS; HUMAN; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TARGETING; PSORIATIC ARTHRITIS; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS;

EID: 84873024174     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/907078     Document Type: Review

References (41)

1. Pietzsch J., Hoppmann S., Human S100A12: a novel key player in inflammation? Amino Acids 2009 36 3 381 389 2-s2.0-67349232760 10.1007/s00726-008-0097-7
2. Guignard F., Mauel J., Markert M., Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 1995 309 2 395 401 2-s2.0-0029041454
3. Heilmann R. M., Suchodolski J. S., Steiner J. M., Purification and partial characterization of canine S100A12. Biochimie 2010 92 12 1914 1922 2-s2.0-78650254406 10.1016/j.biochi.2010.08.007
4. Chen H., Cheng L., Yang S., Liu X., Liu Y., Tang J., Li X., He Q., Zhao S., Molecular characterization, induced expression, and transcriptional regulation of porcine S100A12 gene. Molecular Immunology 2010 47 7-8 1601 1607 2-s2.0-77950628818 10.1016/j.molimm.2010.01.024
5. Yamashita K., Oyama Y., Shishibori T., Matsushita O., Okabe A., Kobayashi R., Purification of bovine S100A12 from recombinant Escherichia coli. Protein Expression and Purification 1999 16 1 47 52 2-s2.0-0033153513 10.1006/prep.1998.1026 (Pubitemid 29321723)
6. Manolakis A. C., Kapsoritakis A. N., Georgoulias P., Tzavara C., Valotassiou V., Kapsoritaki A., Potamianos S. P., Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterology 2010 10, article 118 2-s2.0-77957822435 10.1186/1471-230X-10-118
7. Moore B. W., A soluble protein characteristic of the nervous system. Biochemical and Biophysical Research Communications 1965 19 6 739 744 2-s2.0-0013844612
8. Santamaria-Kisiel L., Rintala-Dempsey A. C., Shaw G. S., Calcium-dependent and -independent interactions of the S100 protein family. Biochemical Journal 2006 396 2 201 214 2-s2.0-33744782044 10.1042/BJ20060195 (Pubitemid 43837235)
9. Ilg E. C., Troxler H., Bürgisser D. M., Kuster T., Markert M., Guignard F., Hunziker P., Birchler N., Heizmann C. W., Amino acid sequence determination of human S100A12 (P6, calgranulin C, CGRP, CAAF1) by tandem mass spectrometry. Biochemical and Biophysical Research Communications 1996 225 1 146 150 2-s2.0-0030570792 10.1006/bbrc.1996.1144 (Pubitemid 26285410)
10. Yang Z., Yan W. X., Cai H., Tedla N., Armishaw C., Di Girolamo N., Wang H. W., Hampartzoumian T., Simpson J. L., Gibson P. G., Hunt J., Hart P., Hughes J. M., Perry M. A., Alewood P. F., Geczy C. L., S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. Journal of Allergy and Clinical Immunology 2007 119 1 106 114 2-s2.0-33845948230 10.1016/j.jaci.2006.08.021 (Pubitemid 46037791)
11. Yilmaz Y., Yonal O., Eren F., Atug O., Over Hamzaoglu H., Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. Journal of Crohn's and Colitis 2011 5 5 402 406 2-s2.0-79953874348 10.1016/j.crohns.2011.03.011
12. Donato R., Intracellular and extracellular roles of S100 proteins. Microscopy Research and Technique 2003 60 6 540 551 2-s2.0-0142229704
13. Maillard-Lefebvre H., Boulanger E., Daroux M., Gaxatte C., Hudson B. I., Lambert M., Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology 2009 48 10 1190 1196 2-s2.0-70350774161
14. Ma C. Y., Ma J. L., Jiao Y. L., The plasma level of soluble receptor for advanced glycation end products is decreased in patients with systemic lupus erythematosus. Scandinavian Journal of Immunology 2012 75 6 614 622
15. Wittkowski H., Hirono K., Ichida F., Vogl T., Ye F., Yanlin X., Saito K., Uese K., Miyawaki T., Viemann D., Roth J., Foell D., Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis and Rheumatism 2007 56 12 4174 4181 2-s2.0-37149020133 10.1002/art.23042 (Pubitemid 350262345)
16. Jiao L., Weinstein S. J., Albanes D., Taylor P. R., Graubard B. I., Virtamo J., Stolzenberg-Solomon R. Z., Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Research 2011 71 10 3582 3589 2-s2.0-79956159720 10.1158/0008-5472.CAN-10-2573
17. Wu J.-F., Jin Z., Yang J.-M., Liu Y.-H., Duan M.-L., Extracranial and intracranial complications of otitis media: 22-year clinical experience and analysis. Acta Oto-Laryngologica 2012 132 3 261 265 2-s2.0-84857202374 10.3109/00016489.2011.643239
18. Liu K., Pichichero M. E., Clinical significance of serum S100A12 in acute otitis media in young children. Pediatric Infectious Disease Journal 2012 31 3 e56 e58 2-s2.0-84857632512 10.1097/INF.0b013e31824672cb
19. Han E. C., Cho S. B., Ahn K. J., Oh S. H., Kim J., Kim D. S., Lee K. H., Bang D., Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet's disease and its association with disease activity: a pilot study. Annals of Dermatology 2011 23 3 313 320 2-s2.0-80052089457 10.5021/ad.2011.23.3.313
20. Kallinich T., Wittkowski H., Keitzer R., Roth J., Foell D., Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Annals of the Rheumatic Diseases 2010 69 4 677 682 2-s2.0-77950334703 10.1136/ard.2009.114363
21. Ozen S., Hoffman H. M., Frenkel J., Kastner D., Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 610 November 2005. Annals of the Rheumatic Diseases 2006 65 7 961 964 2-s2.0-33745686186 10.1136/ard.2006.052688
22. Wittkowski H., Frosch M., Wulffraat N., Goldbach-Mansky R., Kallinich T., Kuemmerle-Deschner J., Frühwald M. C., Dassmann S., Pham T. H., Roth J., Foell D., S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis and Rheumatism 2008 58 12 3924 3931 2-s2.0-57349086217 10.1002/art.24137
23. Foell D., Ichida F., Vogl T., Yu X., Chen R., Miyawaki T., Sorg C., Roth J., S100A12 (EN-RAGE) in monitoring Kawasaki disease. The Lancet 2003 361 9365 1270 1272 2-s2.0-0242500281 10.1016/S0140-6736(03)12986-8 (Pubitemid 36428584)
24. Ye F., Foell D., Hirono K. I., Vogl T., Rui C., Yu X., Watanabe S., Watanabe K., Uese K. I., Hashimoto I., Roth J., Ichida F., Miyawaki T., Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. American Journal of Cardiology 2004 94 6 840 844 2-s2.0-4544333406 10.1016/j.amjcard.2004.05.076 (Pubitemid 39221519)
25. Komatsuda A., Ohtani H., Wakui H., Chyzh K. A., Hatakeyama T., Iwamoto K., Maki N., Kimura T., Hitomi J., Sawada K., Increased serum levels of S100A12 in patients with MPO-ANCA-associated glomerulonephritis. Clinical Nephrology 2006 66 5 315 321 2-s2.0-33750846407 (Pubitemid 44718142)
26. Kaiser T., Langhorst J., Wittkowski H., Becker K., Friedrich A. W., Rueffer A., Dobos G. J., Roth J., Foell D., Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007 56 12 1706 1713 2-s2.0-36749098918 10.1136/gut.2006.113431 (Pubitemid 350206297)
27. Manolakis A. C., Kapsoritakis A. N., Tiaka E. K., Potamianos S. P., Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Digestive Diseases and Sciences 2011 56 6 1601 1611 2-s2.0-79959736367 10.1007/s10620-010-1494-9
28. Foell D., Wittkowski H., Roth J., Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut 2009 58 6 859 868 2-s2.0-66649100476 10.1136/gut.2008.170019
29. Leach S. T., Yang Z., Messina I., Song C., Geczy C. L., Cunningham A. M., Day A. S., Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007 42 11 1321 1331 2-s2.0-35148869758 10.1080/00365520701416709 (Pubitemid 47537067)
30. Foell D., Kucharzik T., Kraft M., Vogl T., Sorg C., Domschke W., Roth J., Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003 52 6 847 853 2-s2.0-0038576426 10.1136/gut.52.6.847 (Pubitemid 36613492)
31. Brinar M., Cleynen I., Coopmans T., Van Assche G., Rutgeerts P., Vermeire S., Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut 2010 59 12 1728 1729 2-s2.0-78649857801 10.1136/gut.2009.194100
32. Myles A., Viswanath V., Singh Y. P., Aggarwal A., Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Journal of Rheumatology 2011 38 9 1994 1999 2-s2.0-80052324298 10.3899/jrheum.110058
33. Aziez O. A. A., Saber N. Z., Bakry S. A. E., Mohammad A. A., Maksud S. S. A., Ali Y., Serum S100A12 and temporomandibular joint magnetic resonance imaging in Juvenile idiopathic arthritis Egyptian patients: a case control study. Pakistan Journal of Biological Sciences 2010 13 3 101 113 2-s2.0-76849093789 10.3923/pjbs.2010.101.113
34. Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., FitzGerald O., Roth J., Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 2003 42 11 1383 1389 2-s2.0-0242441020 10.1093/rheumatology/keg385 (Pubitemid 37407031)
35. Foell D., Seeliger S., Vogl T., Koch H. G., Maschek H., Harms E., Sorg C., Roth J., Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003 58 7 613 617 2-s2.0-0038015368 10.1136/thorax.58.7.613 (Pubitemid 36808133)
36. Wittkowski H., Sturrock A., Van Zoelen M. A. D., Viemann D., Van Der Poll T., Hoidal J. R., Roth J., Foell D., Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Critical Care Medicine 2007 35 5 1369 1375 2-s2.0-34247361667 10.1097/01.CCM.0000262386.32287.29 (Pubitemid 46642668)
37. Garvey J., Infant respiratory distress syndrome. American Journal of Nursing 1975 75 4 614 617 2-s2.0-0016489285
38. Loughran-Fowlds A., Leach S., Lin J., Oei J., Henry R., Day A. S., Lui K., Respiratory disease and early serum S100A12 changes in very premature infants. Acta Paediatrica 2011 100 12 1538 1543 2-s2.0-79960052623 10.1111/j.1651-2227.2011.02384.x
39. Kim J.-K., Park S., Lee M. J., Song Y. R., Han S. H., Kim S. G., Kang S.-W., Choi K. H., Kim H. J., Yoo T.-H., Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 2012 220 1 208 214 2-s2.0-84155160626 10.1016/j.atherosclerosis.2011.07.115
40. Larsen A., Bronstein I. B., Dahl O., Wentzel-Larsen T., Kristoffersen E. K., Fagerhol M. K., Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scandinavian Journal of Immunology 2007 65 2 192 201 2-s2.0-33846619754 10.1111/j.1365-3083.2006.01875.x (Pubitemid 46174928)
41. Brinar M., Cleynen I., Coopmans T., Van Assche G., Rutgeerts P., Vermeire S., Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity. Gut 2010 59 12 1728 1729 2-s2.0-78649857801 10.1136/gut.2009.194100